1. Home
  2. TLSA vs APLT Comparison

TLSA vs APLT Comparison

Compare TLSA & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • APLT
  • Stock Information
  • Founded
  • TLSA 2013
  • APLT 2016
  • Country
  • TLSA United Kingdom
  • APLT United States
  • Employees
  • TLSA N/A
  • APLT N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • APLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TLSA Health Care
  • APLT Health Care
  • Exchange
  • TLSA Nasdaq
  • APLT Nasdaq
  • Market Cap
  • TLSA 87.8M
  • APLT 80.3M
  • IPO Year
  • TLSA 2000
  • APLT 2019
  • Fundamental
  • Price
  • TLSA $0.79
  • APLT $0.65
  • Analyst Decision
  • TLSA
  • APLT Buy
  • Analyst Count
  • TLSA 0
  • APLT 7
  • Target Price
  • TLSA N/A
  • APLT $6.10
  • AVG Volume (30 Days)
  • TLSA 1.1M
  • APLT 3.6M
  • Earning Date
  • TLSA 02-25-2025
  • APLT 03-05-2025
  • Dividend Yield
  • TLSA N/A
  • APLT N/A
  • EPS Growth
  • TLSA N/A
  • APLT N/A
  • EPS
  • TLSA N/A
  • APLT N/A
  • Revenue
  • TLSA N/A
  • APLT N/A
  • Revenue This Year
  • TLSA N/A
  • APLT N/A
  • Revenue Next Year
  • TLSA N/A
  • APLT $2,622.90
  • P/E Ratio
  • TLSA N/A
  • APLT N/A
  • Revenue Growth
  • TLSA N/A
  • APLT N/A
  • 52 Week Low
  • TLSA $0.41
  • APLT $0.54
  • 52 Week High
  • TLSA $1.74
  • APLT $10.62
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 56.56
  • APLT 35.67
  • Support Level
  • TLSA $0.65
  • APLT $0.54
  • Resistance Level
  • TLSA $0.70
  • APLT $0.66
  • Average True Range (ATR)
  • TLSA 0.05
  • APLT 0.06
  • MACD
  • TLSA 0.01
  • APLT 0.09
  • Stochastic Oscillator
  • TLSA 100.00
  • APLT 81.26

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: